Asthma

The newest findings show the TSLP inhibitor is beneficial over 52 weeks in patients aged 12-80 years old.

Meredith McCormack, MD discusses consequences of high air pollution levels in the United States found in the 2021 American Lung Association State of the Air Report.

Climate change health experts Poune Saberi, MD, and Alan S. Greenglass, MD, join Lungcast for a timely discussion on environmental health issues.

The 2021 annual report finds that Los Angeles remains the most polluted US city, while negative impacts of climate change and COVID-19 are both linked to increased pollution rates.

The approval of the sBLA means greater flexibility and reduced barriers in care during the pandemic.

The non-invasive device uses air pressure pulsations to help open airways and provide clearance of secretions in patients with disease such as COPD, asthma, and cystic fibrosis.

Consideration of how immunotherapy may influence other allergic diseases, patient adherence options, and advancing assessment of peanut allergy options.

From interpreting currently-understood risks to managing isolation-induced indoor allergen exposure, asthmatics may have concerns they address with clinicians.

A review of 3 new studies, which indicate the association between severe COVID-19 and the chronic disease is more intricate than previously thought.

From better education, to remote monitoring and consistent check-ins, clinicians may need to initiate better adherence in their younger, severely ill patients.

An interview on the TSLP inhibitor's effect on exacerbations, hospitalizations, and disease progress over 52-week findings.

Oxygen saturation levels similar for both asthma patients and non-asthma patients following mask use.

An interview with a Children's Hospital Colorado investigator on new remote-monitoring research into children's adherence trends.

Common positive effects includes help with sleep, less pain, and calming influence.

An interview with a study author on new interpretations of biologic asthma benefit.

Treatment showed a similar effect on patients with and without baseline asthma.

Researchers explore further endpoints from the SINUS-24 and SINUS-52 trials.

In data presented at AAAAI 2021, researchers present new data from the LIBERTY ASTHMA QUEST trial.

A cohort assessment shows a 57% increased risk of pediatric asthma development among children given PPIs to treat gastrointestinal tract disorders.

Anne Dixon, MD, explains how it took 6 years to update recommendations for new asthma therapies.

A conversation on how associations between the chronic conditions have become better understood in 10 years.

A discussion around obesity's effect on asthma, and the newest recommendations for managed care.

The new federal asthma management guidelines mark the first update of the guidance since 2007.

Many patients with paradoxical vocal fold motion disorder are misdiagnosed, and instead believe they are dealing with asthma. But in many cases, their symptoms do not respond to therapies.

New research adds to the case that some children are genetically more susceptible to allergic disease.